1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Nose Neoplasms: new trials by email Literature Review of Nose Neoplasms trials Research Report on Nose Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) Tabelecleucel, Pembrolizumab - Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms | Phase 1 / Phase 2 | Terminated | Atara Biotherapeutics | 12 | 2019-02-19 | 2024-11-14 |
Carcinoma (1) · Epstein-Barr Virus Infections (1) · Head and Neck Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1) · Pharyngeal Diseases (1) · Pharyngeal Neoplasms (1)
Bone Diseases (1) · Bone Neoplasms (1) · DNA Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Musculoskeletal Diseases (1) · Nose Diseases (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Skull Neoplasms (1) · Tumor Virus Infections (1) · Virus Diseases (1)
pembrolizumab (1)
United States (1)
Aditi Mehta, DO (1)